Other studies have also applied radiomics based on different imaging techniques to predict the expression status of p53 in epithelial ovarian cancer (64), endometrial carcinoma (65), esophageal squamous cell carcinoma (66), and breast ductal carcinoma (67). The gene discussed is TP53; the disease is endometrial carcinoma.